Rituximab for adult primary immune thrombocytopenia

被引:2
|
作者
Frederiksen, Henrik [1 ,2 ]
机构
[1] Odense Univ Hosp, Dept Haematol, DK-5000 Odense, Denmark
[2] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark
来源
LANCET HAEMATOLOGY | 2015年 / 2卷 / 02期
关键词
DEXAMETHASONE MONOTHERAPY;
D O I
10.1016/S2352-3026(15)00006-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E52 / E53
页数:2
相关论文
共 50 条
  • [31] Thrombopoietin receptor agonist and rituximab combination therapy in patients with refractory primary immune thrombocytopenia
    Witkowski, Michal
    Ryzewska, Wiktoria
    Robak, Tadeusz
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (03) : 108 - 114
  • [32] Rituximab for Children with Immune Thrombocytopenia: A Systematic Review
    Liang, Yi
    Zhang, Lingli
    Gao, Ju
    Hu, Die
    Ai, Yuan
    PLOS ONE, 2012, 7 (05):
  • [33] Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
    Kim, Chul Hee
    Choi, Yoon Seok
    Moon, Ji Young
    Kim, Duck Yong
    Lee, So Yeon
    Lee, Hyo Jin
    Yun, Hwan Jung
    Kim, Samyong
    Jo, Deog Yeon
    Song, Ik Chan
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (02): : 383 - +
  • [34] Vaccination Rates in Primary Immune Thrombocytopenia Adult Patients Exposed to Rituximab or Splenectomy. a Nationwide Population-Based Study in France
    Moulis, Guillaume
    Lapeyre-Mestre, Maryse
    Montastruc, Jean-Louis
    Godeau, Bertrand
    Sailler, Laurent
    BLOOD, 2014, 124 (21)
  • [35] Low-Dose Rituximab and High-Dose Dexamethasone As Front-Line Therapy in Adult Patients with Primary Immune Thrombocytopenia
    Gomez-Almaguer, David
    Tarin-Arzaga, Luz C.
    Moreno-Jaime, Brizio
    Jaime-Perez, Jose C.
    Ceballos-Lopez, Adrian A.
    Ruiz-Argueelles, Guillermo J.
    Ruiz-Delgado, Guillermo J.
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar H.
    BLOOD, 2012, 120 (21)
  • [36] Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition
    Hirokazu Kashiwagi
    Masataka Kuwana
    Mitsuru Murata
    Naoki Shimada
    Toshiro Takafuta
    Jun Yamanouchi
    Hisashi Kato
    Takaaki Hato
    Yoshiaki Tomiyama
    International Journal of Hematology, 2024, 119 : 1 - 13
  • [37] VITAMIN D RECEPTOR GENE POLYMORPHISMS IN ADULT PRIMARY IMMUNE THROMBOCYTOPENIA
    Sakr, M.
    HAEMATOLOGICA, 2017, 102 : 834 - 835
  • [38] SECONDARY IMMUNE THROMBOCYTOPENIA IN THE PRIMARY IMMUNODEFICIENCY DISORDER IN ADULT HEMATOLOGICAL PRACTICE
    Melikyan, A. L.
    Egorova, E. K.
    Kalinina, M., V
    Pustovaya, E., I
    Kolosheynova, T., I
    Gilyazitdinova, E. A.
    Subortseva, I. N.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2017, 62 (03): : 159 - 163
  • [39] Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition
    Kashiwagi, Hirokazu
    Kuwana, Masataka
    Murata, Mitsuru
    Shimada, Naoki
    Takafuta, Toshiro
    Yamanouchi, Jun
    Kato, Hisashi
    Hato, Takaaki
    Tomiyama, Yoshiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 1 - 13
  • [40] Risk of cataract in primary immune thrombocytopenia adult patients treated with eltrombopag
    Lafaurie, Margaux
    Baricault, Berangere
    Soler, Vincent
    Cassagne, Myriam
    Sailler, Laurent
    Lapeyre-Mestre, Maryse
    Sommet, Agnes
    Moulis, Guillaume
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 601 - 601